Literature DB >> 3794893

Teratogenicity of cocaine in humans.

N Bingol, M Fuchs, V Diaz, R K Stone, D S Gromisch.   

Abstract

To study teratogenicity of cocaine in humans, we studied three groups of pregnant women and their offspring: group 1, 50 women who abused cocaine only; group 2, 110 women who were polydrug abusers; and group 3, 340 who were drug free. All three groups were similar for socioeconomic status, cigarette smoking, and ethnicity. Maternal age of group 1 was similar to that of group 3, but group 2 mothers were significantly older. Gravidity was significantly higher in groups 1 and 2 compared with group 3. No statistical difference was found in spontaneous abortion rate among the three groups, but the stillbirth rate was significantly higher in group 1 (chi 2 = 6.89, P less than or equal to 0.01). All stillbirths were related to abruptio placentae. Birth weight, length, and head circumference were significantly decreased in infants in groups 1 and 2 compared with group 3 (P less than or equal to 0.0001), but no statistical difference was found between groups 1 and 2. The congenital malformation rate was significantly higher in group 1 compared with group 3 (chi 2 = 7.07, P less than or equal to 0.01). We conclude that cocaine abuse in humans significantly reduces weight of the fetus, increases the stillbirth rate related to abruptio placentae, and is associated with a higher malformation rate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3794893     DOI: 10.1016/s0022-3476(87)80297-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  32 in total

Review 1.  The effects of maternal cocaine abuse on mothers and newborns.

Authors:  K Kaltenbach
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 2.  Clinical toxicology of cocaine.

Authors:  K A Loper
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

3.  Dysmorphic and anthropometric outcomes in 6-year-old prenatally cocaine-exposed children.

Authors:  Sonia Minnes; Nathaniel H Robin; April A Alt; H Lester Kirchner; Sudtida Satayathum; Bonnie Anne Salbert; Laurie Ellison; Lynn T Singer
Journal:  Neurotoxicol Teratol       Date:  2005-11-18       Impact factor: 3.763

Review 4.  Pharmacokinetics of cocaine in pregnancy and effects on fetal maturation.

Authors:  R C Wiggins
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

Review 5.  Perinatal effects of cocaine and amphetamine use during pregnancy.

Authors:  S R Kandall
Journal:  Bull N Y Acad Med       Date:  1991 May-Jun

6.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

Review 7.  Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience.

Authors:  R Loebstein; G Koren
Journal:  J Psychiatry Neurosci       Date:  1997-05       Impact factor: 6.186

Review 8.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

9.  Selective neuronal toxicity of cocaine in embryonic mouse brain cocultures.

Authors:  M C Nassogne; P Evrard; P J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk.

Authors:  David S Bennett; Margaret Bendersky; Michael Lewis
Journal:  Dev Psychol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.